The Endocrine Society continues to advocate for insulin affordability. Although new legislation to make insulin more affordable has been stalled in Congress, the Centers for Medicare and Medicaid Services (CMS) continues to advance a program to implement drug price negotiations to lower the cost of certain prescription drugs, including several diabetes medications. CMS recently hosted […]
Endocrine Society Continues to Advocate for Insulin Affordability
Join the Global Movement Advancing Endocrine Science and Medicine
Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.